Kevin Daniels - 31 Dec 2023 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Role: CAO & Treasurer
Signature: /s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol: CLB
Transactions as of: 31 Dec 2023
Transactions value $: -$48,901
Form type: 4
Filing time: 03 Jan 2024, 17:47:05 UTC
Previous filing: 04 Dec 2023
Next filing: 15 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLB	Common Stock	Tax liability	-$48.9K	-2.77K	-17.36%	$17.66	13.2K	31 Dec 2023	Direct
transaction	CLB	Common Stock	Options Exercise	$0	+7.2K	+82.3%	$0.00	15.9K	31 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLB	Performance Shares	Options Exercise	$0	-7.2K	-100%	$0.00^*	0	31 Dec 2023	Common Stock	7.2K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on Decmeber 31, 2023 at the conclusion of the performance period.